ctrl K

Watchlist Price Alert

Alexion Pharmaceuticals I... (ALXN)

NASDAQ: ALXN · Real-Time Price · USD

182.50

0.00 (0.00%)

At close: Apr 24, 2025, 3:47 PM

Alexion Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	2.96B	2.69B	1.37B	584.4M	966M
Short-Term Investments	34.9M	64M	198.3M	889.7M	327M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	506.2M	633.3M	397.2M	312.6M	299M
Receivables	1.41B	1.24B	922.3M	726.5M	650M
Inventory	775.7M	627.6M	472.5M	460.4M	375M
Other Current Assets	648.6M	456.1M	426.4M	292.9M	260M
Total Current Assets	5.83B	5.08B	3.38B	2.95B	2.58B
Property-Plant & Equipment	1.46B	1.16B	1.47B	1.32B	1.04B
Goodwill & Intangibles	8.1B	8.38B	8.68B	8.99B	9.34B
Total Long-Term Assets	12.27B	12.47B	10.55B	10.63B	10.68B
Total Assets	18.1B	17.54B	13.93B	13.58B	13.25B
Account Payables	118.6M	74M	74.4M	70.8M	64M
Deferred Revenue	150.9M	103.9M	24.4M	15.9M	37M
Short-Term Debt	142.4M	126.7M	343.8M	167.4M	167M
Other Current Liabilities	1.21B	889.7M	731.4M	698.4M	555M
Total Current Liabilities	1.62B	1.19B	1.17B	952.5M	823M
Long-Term Debt	2.42B	2.38B	2.5B	2.72B	2.89B
Other Long-Term Liabilities	775.3M	622.1M	699.8M	652M	452M
Total Long-Term Liabilities	4.83B	5.08B	3.59B	3.74B	3.74B
Total Liabilities	6.45B	6.27B	4.77B	4.69B	4.56B
Total Debt	2.56B	2.5B	2.85B	2.89B	3.06B
Common Stock	n/a	n/a	n/a	n/a	n/a
Retained Earnings	5.24B	4.64B	2.33B	2.24B	1.82B
Comprehensive Income	-124.6M	-66.8M	-9.7M	-34.4M	60M
Shareholders Equity	11.65B	11.27B	9.17B	8.89B	8.69B
Total Investments	34.9M	64M	198.3M	889.7M	327M